Skip to main content

Table 2 Mean values at baseline and post-treatment for spirometric and other parameters

From: Efficacy and safety of inhaled formoterol 4.5 and 9 μg twice daily in Japanese and European COPD patients: Phase III study results

 

Placebo

(n = 208)

Formoterol 4.5 μg

(n = 206)

Formoterol 9 μg

(n = 199)

60-min post-dose FEV1, L

   

   Baseline

1.23

1.18

1.16

   Post-treatment

1.25

1.33

1.31

   Ratio to baseline (%)

101.3

112.6

113.4

Pre-dose FEV1, L

   

   Baseline

1.23

1.18

1.16

   Post-treatment

1.24

1.23

1.21

   Ratio to baseline (%)

99.8

104.5

104.7

5-min post-dose FEV1, L

   

   Baseline

1.23

1.18

1.16

   Post-treatment

1.24

1.30

1.28

   Ratio to baseline (%)

101.3

110.2

110.2

60-min post-dose FVC, L

   

   Baseline

2.77

2.71

2.61

   Post-treatment

2.82

2.98

2.87

   Ratio to baseline (%)

102.1

109.7

109.9

Pre-dose FVC, L

   

   Baseline

2.77

2.71

2.61

   Post-treatment

2.80

2.81

2.70

   Ratio to baseline (%)

100.7

103.6

103.4

5-min post-dose FVC, L

   

   Baseline

2.77

2.71

2.61

   Post-treatment

2.80

2.94

2.84

   Ratio to baseline (%)

101.6

108.5

108.9

Morning PEF, L/min

   

   Run-in

223.8

211.9

215.0

   Treatment

227.6

228.1

233.5

   Change from run-in

3.6

16.3

18.3

Evening PEF, L/min

   

   Run-in

233.8

221.4

221.9

   Treatment

236.5

234.6

237.5

   Change from run-in

2.4

13.2

15.8

Night-time awakening, score/day

   

   Run-in

0.73

0.66

0.83

   Treatment

0.68

0.53

0.66

   Change from run-in

-0.05

-0.13

-0.17

Breathlessness, score/day

   

   Run-in

1.65

1.51

1.72

   Treatment

1.38

1.11

1.28

   Change from run-in

-0.26

-0.41

-0.45

Cough, score/day

   

   Run-in

1.46

1.44

1.63

   Treatment

1.26

1.11

1.21

   Change from run-in

-0.20

-0.33

-0.41

Total symptom score

   

   Run-in

3.84

3.61

4.19

   Treatment

3.32

2.75

3.14

   Change from run-in

-0.51

-0.86

-1.04

Use of salbutamol, inhalations/day

   

   Run-in

1.86

2.09

2.40

   Treatment

1.63

1.52

1.50

   Change from run-in

-0.23

-0.60

-0.97

SGRQ total score

   

   Baseline

44.9

43.4

44.0

   Last available score

42.9

38.2

38.2

   Change from baseline

-2.0

-5.5

-6.4